Kauppinen R, et al. - Researchers analyzed adult-onset, newly diagnosed asthma in steroid-naïve patients (n = 162) in this investigator-driven, real-life follow-up study in order to determine the consequences of therapy over the 25-year course of the disease, and to find out if long-term prognosis can be predicted by the first treatment year's forced expiratory volume in one second (FEV₁). In the 25-year examinations, 83% of the 133 living patients participated. The later lung function level in adult-onset asthma appeared to be predicted by the level of FEV₁ attained during the first treatment year. The cessation of the asthma treatment was reported in one quarter of the patients, but these individuals had better health-related quality of life as compared with those continuing to use ICS. Overall, 16% of patients achieved clinical remission, which is in concordance with other studies.